Edward Eunkee Whang, MD
Adjunct Associate Professor
Boston University Chobanian & Avedisian School of Medicine
Surgery
General Surgery

MD, Pritzker School of Medicine
BS, Massachusetts Institute of Technology



Dr. Whang, MD is a practicing Surgeon in Boston, MA. Dr. Whang graduated from University of Chicago Pritzker School of Medicine in 1991 and has been in practice for 28 years. He completed a residency at UCLA Medical Center. Dr. Whang is board certified in Surgery. Dr. Whang also practices at Boston Vamc in Jamaica Plain, MA.

VA Boston Healthcare System


Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Duxbury MS, Ito H, Benoit E, Zinner MJ, Ashley SW, Whang EE. Editorial Expression of Concern: Overexpression of CEACAM6 promotes insulin-like growth factor I-induced pancreatic adenocarcinoma cellular invasiveness. Oncogene. 2023 Aug; 42(34):2589. PMID: 37468680
     
  2. Duxbury MS, Ito H, Ashley SW, Whang EE. Withdrawal: CEACAM6 cross-linking induces caveolin-1-dependent, Src-mediated focal adhesion kinase phosphorylation in BxPC3 pancreatic adenocarcinoma cells. J Biol Chem. 2023 Jul; 299(7):105007. PMID: 37429045; PMCID: PMC10339168; DOI: 10.1016/j.jbc.2023.105007;
     
  3. Foroushani S, Gaetani RS, Lin B, Chugh P, Siegel A, Whang E, Kristo G. Role Reversal Between Trainees and Surgeons: Improving Autonomy and Confidence in Surgical Residents. J Surg Res. 2023 Sep; 289:75-81.View Related Profiles. PMID: 37086599
     
  4. Duxbury MS, Ito H, Zinner MJ, Ashley SW, Whang EE. Retraction Note: CEACAM6 gene silencing impairs anoikis resistance and in vivo metastatic ability of pancreatic adenocarcinoma cells. Oncogene. 2023 Mar; 42(12):939. PMID: 36765147
     
  5. Duxbury MS, Ito H, Zinner MJ, Ashley SW, Whang EE. Retraction Note: RNA interference targeting the M2 subunit of ribonucleotide reductase enhances pancreatic adenocarcinoma chemosensitivity to gemcitabine. Oncogene. 2023 Mar; 42(14):1157. PMID: 36797340
     
  6. Duxbury MS, Ito H, Zinner MJ, Ashley SW, Whang EE. Retraction Note: EphA2: a determinant of malignant cellular behavior and a potential therapeutic target in pancreatic adenocarcinoma. Oncogene. 2023 Mar; 42(12):938. PMID: 36759574
     
  7. Ito H, Duxbury M, Zinner MJ, Ashley SW, Whang EE. Retraction notice to Glucose transporter-1 gene expression is associated with pancreatic cancer invasiveness and MMP-2 activity [Surgery -September 2004, Pages 548-556]. Surgery. 2023 Apr; 173(4):1108. PMID: 36781314
     
  8. Duxbury MS, Ito H, Benoit E, Zinner MJ, Ashley SW, Whang EE. Retraction notice to 36774320
     
  9. He K, Sell NM, Chugh P, Rasic G, Collado L, Smink DS, Whang E, Kristo G. Improving the financial wellness of general surgery residents: A nationwide survey. Am J Surg. 2022 Sep; 224(3):888-892.View Related Profiles. PMID: 35545475
     
  10. Pastrana Del Valle J, Fillmore NR, Molina G, Fairweather M, Wang J, Clancy TE, Ashley SW, Urman RD, Whang EE, Gold JS. ASO Visual Abstract: Socioeconomic Disparities in Pancreas Cancer Resection and Survival in the Veterans Health Administration. Ann Surg Oncol. 2022 May; 29(5):3205. PMID: 35132489
     
Showing 10 of 173 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 173 publications over 29 distinct years, with a maximum of 28 publications in 2004

YearPublications
19941
19953
19963
19971
19981
19991
20006
20014
20027
200315
200428
200510
20065
20074
20088
20096
20104
20114
20123
20131
20153
20163
20178
20185
20197
202012
20219
20223
20238

Contact for Mentoring:

Whang's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Co-Authors
_
Similar People
_
Same Department